Health Insurance- The Best Backup Plan in Today’s Times Medical Dialogues Bureau13 Nov 2019 6:14 AM GMTHealthcare delivery sector is advancing at a lightening pace with doctors now capable to threatening many threatening diseases that earlier were...
Syngene reports robust 11% YOY revenue growth in Q2 FY20 Medical Dialogues Bureau23 Oct 2019 6:48 AM GMTBengaluru: Syngene International Limited recently announced its Q2 FY20 results posting quarterly revenue of Rs. 485 Cr, an increase of 11% from the...
Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy Medical Dialogues Bureau19 Aug 2019 10:13 AM GMTHarmony Biosciences, LLC (Harmony) announced that the U.S. Food and Drug Administration (FDA) approved WAKIX (pitolisant) for the treatment of...
HCL Technologies and Oracle Health Sciences Collaborate to Accelerate MHealth in Clinical Trials Medical Dialogues Bureau6 Aug 2019 11:07 AM GMTHCL Technologies (HCL), a leading global technology company and a Platinum-Level member of Oracle Partner Network (OPN), and Oracle Health Sciences...
USFDA completes inspection at Laurus Labs' AP unit Medical Dialogues Bureau19 July 2019 4:32 AM GMTMumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH Medical Dialogues Bureau19 Jun 2019 6:31 AM GMTAHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
USFDA permits marketing of first medical device for treatment of ADHD Medical Dialogues Bureau21 April 2019 4:56 AM GMTThe U.S. Food and Drug Administration permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The...
USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose Medical Dialogues Bureau21 April 2019 3:57 AM GMTThe U.S. Food and Drug Administration granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a...
Desi AI based healthtech startup NIRAMAI raises Rs 42.6 Crore in Series A Funding Garima25 Feb 2019 10:34 AM GMTBengaluru: Artificial intelligence based health tech startup NIRAMAI Health Analytics, has announced that it has closed $6 mn in a Series A round of...
Hetero Labs Limited acquires Tarbis Farma in Spain Medical Dialogues Bureau3 Jan 2019 3:45 AM GMTThe acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio, manp...
SCHOTT KAISHA launches customizable prefillable glass syringes in India Medical Dialogues Bureau1 Jan 2019 4:00 AM GMTRishad Dadachanji, Director, SCHOTT KAISHA shares, “The syriQ BioPure syringes, manufactured in St. Gallen, Switzerland, combine features to ensure sta...
True Properties of Vitamin E Overlooked: Merck Launches Book for Awareness Medical Dialogues Bureau21 Oct 2018 6:31 AM GMTMumbai: Merck Consumer Health India - a leader in Vitamin E in India - announced the publication of the country’s first handbook that highlights the...
